Results 111 to 120 of about 7,551 (201)

A cost utility and cost effectiveness analysis of different oral antiviral medications in patients with HBeAg-Negative chronic hepatitis B in Iran: an economic microsimulation decision model [PDF]

, 2016
Background: Although hepatitis B infection is the major cause of chronic liver disease in Iran, no studies have employed economic evaluations of the medications used to treat Iranian patients with chronic hepatitis B (CHB).
Alavian, Seyed Moayed, Javanbakht, Mehdi, Kebriaeezadeh, Abbas, Keshavarz, Khosro, Keshvari, Maryam, Lotfi, Farhad, Meshkini, Amir Hashemi, Nikfar, Shekoufeh, Rezaei Hemami, Mohsen, Sari, Ali Akbari   +9 more
core   +1 more source

Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG

Scientific Reports, 2017
Aberrant IgG glycosylation is a feature of hepatitis B virus (HBV) infection but its effect on a long-term efficacy of antiviral therapy has never been addressed.
Cheng-Hsun Ho, Hung-Wen Tsai, Chen-Yeh Lee, Li-Juan Huang, Rong-Nan Chien, I-Chin Wu, Yen-Cheng Chiu, Wen-Chun Liu, Pin-Nan Cheng, Ting-Tsung Chang, Shu-Hui Chen   +10 more
doaj   +1 more source

Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon-α monotherapy. [PDF]

J Clin Lab Anal, 2022
Shang H, Hu Y, Guo H, Lai R, Fu Y, Xu S, Zeng Y, Xun Z, Liu C, Wu W, Guo J, Ou Q, Chen T.   +12 more
europepmc   +1 more source

Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series.

European review for medical and pharmacological sciences, 2010
We report a case series of three HBeAg positive and five HBeAg negative patients (7 males, mean age 50.6 +/- 14.6 years) with chronic HBV infection experiencing seroconversion after treatment with entecavir (0.5 mg/day or 1 mg/day), initiated in 2007. Overall, the mean time to HBsAg clearance was 9.4 +/- 4.5 months.
G. D'Ettorre, G. Barbarini, F. Corti, M. Gobber, C. Pastecchia, G. L. Ricci, M. Siciliano, B. E. Annicchiarico, VULLO, Vincenzo   +8 more
openaire   +2 more sources

An Observational Study to Evaluate the Safety and Efficacy of Telbivudine in Adults with Chronic Hepatitis B

Acta Medica Indonesiana, 2016
Aim: to assess the safety and efficacy of telbivudine therapy in adult patients with CHB in Indonesia. Methods: the study design was prospective cohort study.
Ali Sulaiman, Laurentius A Lesmana, Nafrialdi Nafrialdi, Helyanna Helyanna   +3 more
doaj   +4 more sources

The decline of HBV RNA associated with HBeAg seroconversion and double-negative HBV DNA and RNA in chronic hepatitis B patients who received entecavir therapy: a 10-year retrospective cohort study. [PDF]

Ann Transl Med, 2022
Ye F, Zhao W, Yang X, Zhang X, An X, Zhu R, Chen Y, Liu X, Li J, Li K, Zheng J, Lin S, Shi L.   +12 more
europepmc   +1 more source

Development and validation of a multivariable nomogram predictive of hepatitis B e antigen seroconversion after pregnancy in hepatitis B virus-infected mothers

Frontiers in Medicine
Background and aimsCurrent guidelines are controversial regarding the continuation of nucleos(t)ide analogues (NAs) therapy after delivery in Hepatitis B virus (HBV)-infected pregnant women.
Wenting Zhong, Jie Zheng, Che Wang, Lei Shi, Yingli He, Yingren Zhao, Tianyan Chen   +6 more
doaj   +1 more source

Plasma Level of ADAMTS13 or IL-12 as an Indicator of HBeAg Seroconversion in Chronic Hepatitis B Patients Undergoing m-ETV Treatment. [PDF]

Front Cell Infect Microbiol, 2020
Yang J, Guo R, Yan D, Lu H, Zhang H, Ye P, Jin L, Diao H, Li L.   +8 more
europepmc   +1 more source

[HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy].

The Korean journal of hepatology, 2006
Viral suppression of the hepatitis B virus (HBV) can be induced by lamivudine, but the relapse seen in many patients after cessation of lamivudine therapy is troublesome. We thought that the host immune response is important to prevent viral relapse.
Chun Kyon, Lee, Kwang-Hyub, Han, Jeong Hun, Suh, Young Suk, Cho, Sun Young, Won, Chae Yoon, Chon, Young Myoung, Moon, In Suh, Park   +7 more
openaire   +1 more source

Early Serum HBV pgRNA and HBeAg Drop combinedly Predicted HBeAg Seroconversion in Chinese Patients Treated with Entecavir or Interferon

, 2020
Figure S1. The relationship between serum HBV pgRNA and HBsAg or HBeAg levels in all patients. (A) The correlation between serum pgRNA and HBsAg levels at baseline. (B) The correlation between serum pgRNA and HBsAg levels at week 48. (C) The correlation between serum pgRNA and HBeAg levels at baseline.
openaire   +1 more source